Literature DB >> 9635623

Hepatitis G and C viruses respond to interferon-alpha with different virologic kinetics.

G Yang1, F X Caroli-Bosc, C Laffont, D Bianchi, S Dantin, J C Lefebvre, A Doglio.   

Abstract

The aim of this work was to specify the time course of response to interferon (IFN) of hepatitis G virus (HGV) and hepatitis C virus (HCV) in coinfected individuals. A group of 33 patients, undergoing 12 months of IFN therapy for chronic hepatitis C, was screened for the presence of both HGV and HCV RNAs to select seven coinfected patients. Spontaneous recovery from HGV infection was excluded through the detection of antibodies to the envelope-2 protein of HGV and HCV isolates were genotyped. Within three months of treatment, we found that HGV RNA was transiently cleared in 6/7 patients, but the rate of long-term favorable response was very low (1/7). In addition, considering the same individuals separately, it was shown that HGV and HCV responded to IFN with different kinetics in 5/7 patients. Taken together, these results underscore the importance of the virological basis of the resistance to IFN treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635623     DOI: 10.1023/a:1018824311722

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.

Authors:  T Berg; U Dirla; U Naumann; H G Heuft; S Küther; H Lobeck; E Schreier; U Hopf
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

2.  Hepatitis G virus infection: clinical characteristics and response to interferon.

Authors:  P Karayiannis; S J Hadziyannis; J Kim; J M Pickering; M Piatak; G Hess; A Yun; M J McGarvey; J Wages; H C Thomas
Journal:  J Viral Hepat       Date:  1997-01       Impact factor: 3.728

3.  Hepatitis G virus: identification, prevalence and unanswered questions.

Authors:  P Karayiannis; H C Thomas
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

4.  The cloning and clinical implications of HGV and HGBV-C.

Authors:  H J Alter
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

5.  Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.

Authors:  M Martinot; P Marcellin; N Boyer; J Detmer; M Pouteau; C Castelnau; C Degott; A Aupérin; M Collins; J Kolberg; J Wilber; J P Benhamou; S Erlinger
Journal:  Ann Intern Med       Date:  1997-06-01       Impact factor: 25.391

6.  Histopathologic impact of GB virus C infection on chronic hepatitis C.

Authors:  M P Bralet; F Roudot-Thoraval; J M Pawlotsky; A Bastie; J Tran Van Nhieu; J Duval; D Dhumeaux; E S Zafrani
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

7.  Detection of antibodies to a putative hepatitis G virus envelope protein.

Authors:  M Tacke; K Kiyosawa; K Stark; V Schlueter; B Ofenloch-Haehnle; G Hess; A M Engel
Journal:  Lancet       Date:  1997-02-01       Impact factor: 79.321

Review 8.  Therapy of acute and chronic viral hepatitis.

Authors:  J H Hoofnagle
Journal:  Adv Intern Med       Date:  1994

9.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

Review 10.  Variability of hepatitis C virus.

Authors:  P Simmonds
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

View more
  1 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.